Zilarbi CT 40mg/6.25mg Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Azilsartan medoxomil (40mg) + Chlorthalidone (6.25mg)
Overview Zilarbi CT 40mg/6.25mg Tablet
Combiflex HT 40mg/6.25mg tablets treat high blood pressure by promoting vasodilation and improving cardiac output. This dual-action medication also facilitates diuresis and electrolyte regulation. Administer Combiflex HT at the same time each day, with or without food, as directed by your physician. Dosage and frequency depend on individual needs; complete the prescribed course, even if symptoms improve. Abrupt cessation should be avoided; consult your doctor before stopping treatment. Potential side effects include fatigue, hypokalemia, hypotension, elevated creatinine, and hyperuricemia. Maintain adequate hydration. Dizziness may occur; avoid activities requiring alertness until effects are known. Regular blood pressure monitoring is essential. Inform your physician of pregnancy, breastfeeding, circulatory disorders, liver or kidney issues, and all other medications before commencing treatment, as drug interactions may reduce efficacy or alter the medication's action.
Primary Ingredients of Zilarbi CT 40mg/6.25mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Zilarbi CT 40mg/6.25mg Tablet
Elevated blood pressure
Major Benefits of Zilarbi CT 40mg/6.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zilarbi CT 40mg/6.25mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistency in timing is recommended.
Common Side effects of Zilarbi CT 40mg/6.25mg Tablet:
- Dizziness
- Tiredness
- Decreased potassium level in blood
- Decreased blood pressure
- Increased creatinine level in blood
- Increased uric acid level in blood
How to use Zilarbi CT 40mg/6.25mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Zilarbi CT 40mg/6.25mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, but consistency in timing is recommended.
How Zilarbi CT 40mg/6.25mg Tablet works:
Each Zilarbi CT 40mg/6.25mg tablet combines azilsartan medoxomil, an angiotensin receptor blocker (ARB), with chlorthalidone, a diuretic, to produce a significant reduction in blood pressure. Azilsartan medoxomil achieves this by inhibiting angiotensin, a hormone that constricts blood vessels; this improved vascular tone facilitates easier blood flow and enhanced cardiac function. Chlorthalidone's diuretic action eliminates excess fluid and electrolytes, contributing to lower blood pressure via a secondary vasodilatory effect and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Zilarbi CT 40mg/6.25mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Zilarbi CT 40mg/6.25mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Zilarbi CT 40mg/6.25mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Taking Zilarbi CT 40mg/6.25mg tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Zilarbi CT 40mg/6.25mg tablets, as dosage modification may be necessary. A physician's consultation is advised; the use of Zilarbi CT 40mg/6.25mg tablets is generally not recommended for such patients.
LiverCAUTION
Patients with liver impairment should use Zilarbi CT 40mg/6.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Zilarbi CT 40mg/6.25mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Zilarbi CT 40mg/6.25mg Tablet :
Should you forget to take your Zilarbi CT 40mg/6.25mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Zilarbi CT 40mg/6.25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | HEART |
3,018 People bought this recently